SomaLogic licenses protein-diagnostic platform to Israeli biotech firm

BOULDER — SomaLogic Inc. (Nasdaq: SLGC), a Boulder-based biotechnology company, has licensed its SomaScan protein-diagnostics platform to Israeli life-sciences firm OncoHost Inc. SomaLogic develops platforms to read thousands of proteins … Continued
Source: BizWest

Related Articles